Related Experiment Video

Updated: Feb 17, 2026

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
08:45

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Published on: May 10, 2022

2.4K

Paediatric age-dependent serum transferrin isoform distribution studied by HPLC

Torsten Arndt1, Sven Stanzel, Adrian C Sewell

  • 1Bioscientia Institut fuer Medizinische Diagnostik GmbH, 55218 Ingelheim, Germany. torsten.arndt@bioscientia.de

Clinical Laboratory
|February 9, 2008
PubMed

Insights

Transferrin isoforms in children show age-dependent changes, with pentasialotransferrin decreasing with age. Asialo- and monosialotransferrin are considered abnormal in pediatric serum.

Area of Science:

  • Biochemistry
  • Clinical Chemistry
  • Pediatric Medicine

Background:

  • Human serum transferrin exists in various isoforms based on glycosylation levels, ranging from asialo- to octasialotransferrin.
  • Understanding age-dependent variations in transferrin isoform distribution is crucial for accurate clinical interpretation.

Purpose of the Study:

  • To investigate age-dependent differences in transferrin isoform distribution in pediatric patients.
  • To establish reference ranges for transferrin isoforms in children.

Main Methods:

  • Serum samples from 126 pediatric patients across seven age groups were analyzed using High-Performance Liquid Chromatography (HPLC).
  • Statistical analysis, including calculation of means, medians, and percentiles, was performed for each transferrin isoform to identify significant age-related differences.

Main Results:

  • Carbohydrate-deficient transferrin (CDT), corresponding to disialotransferrin, showed no significant age-related differences.
  • Trisialotransferrin and tetrasialotransferrin also exhibited no statistically significant age-dependent variations.
  • Pentasialotransferrin demonstrated a statistically significant decrease with increasing age in pediatric serum.

Conclusions:

  • Age-independent decision limits for disialotransferrin (95th percentile: 1.1%) and trisialotransferrin (95th percentile: 5.3%) are proposed for differentiating normal from elevated levels in children.
  • The detection of asialotransferrin and monosialotransferrin in pediatric serum should be considered indicative of an abnormal condition.
Abstract

More Related Videos

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay05:08

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay

Published on: January 31, 2022

5.6K
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

2.0K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
335
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
323
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
337
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
268
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
256
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
284